Anticonvulsants
Research conducted by a team of neurologists at Sichuan University has shed light on the most effective treatment combinations for patients with epilepsy who have failed to respond to sodium valproate monotherapy. The study aimed to compare the therapeutic efficacy of five anti-seizure medication combinations: valproate plus lamotrigine, levetiracetam, oxcarbazepine,
Anticonvulsants
Research conducted by a team of neurologists at Sichuan University has shed light on the most effective treatment combinations for patients with epilepsy who have failed to respond to sodium valproate monotherapy. The study aimed to compare the therapeutic efficacy of five anti-seizure medication combinations: valproate plus lamotrigine, levetiracetam, oxcarbazepine,
Anticonvulsants
Research conducted by a team of neurologists at Sichuan University has shed light on the most effective treatment combinations for patients with epilepsy who have failed to respond to sodium valproate monotherapy. The study aimed to compare the therapeutic efficacy of five anti-seizure medication combinations: valproate plus lamotrigine, levetiracetam, oxcarbazepine,
Anticonvulsants
A new study published in The Journal of the American Medical Association (JAMA) by Northwell Health clinicians and researchers has found that individuals with newly diagnosed focal epilepsy who have a history of frequent seizures and psychiatric disorders are more likely to be resistant to anti-seizure medications. The study, co-led
Anticonvulsants
In a midphase trial, Praxis Precision Medicines observed a 56.3% median reduction in seizure frequency from baseline, a promising sign for the company's sodium-channel modulator vormatrigine in treating epilepsy. The Radiant study involved 37 patients with focal onset seizures who received vormatrigine, with 23% of patients discontinuing
Anticonvulsants
Researchers at University College London (UCL) have made a significant breakthrough in the treatment of epilepsy, a neurological disorder that affects millions of people worldwide. According to a new study published in the Journal of Seizure, a promising strategy to overcome drug-resistance in epilepsy involves the co-administration of a P-glycoprotein
Anticonvulsants
Research conducted by Teerthanker Mahaveer Medical College and Research Centre has shed light on the effectiveness of newer antiepileptic drugs (AEDs) in improving the quality of life for patients with epilepsy. The study, published in the Indian Journal of Physiology and Pharmacology, found that patients receiving newer AEDs showed significant
